Your browser doesn't support javascript.
loading
Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center Analysis.
Stelmach, Patrick; Wethmar, Klaus; Groth, Christoph; Wenge, Daniela V; Albring, Jörn; Mikesch, Jan-Henrik; Schliemann, Christoph; Reicherts, Christian; Berdel, Wolfgang E; Lenz, Georg; Stelljes, Matthias.
Afiliação
  • Stelmach P; Department of Medicine A - Hematology, Hemostaseology, Oncology, Pulmonology, University Hospital Münster, Münster, Germany.
  • Wethmar K; Department of Medicine A - Hematology, Hemostaseology, Oncology, Pulmonology, University Hospital Münster, Münster, Germany.
  • Groth C; Department of Medicine A - Hematology, Hemostaseology, Oncology, Pulmonology, University Hospital Münster, Münster, Germany.
  • Wenge DV; Department of Medicine A - Hematology, Hemostaseology, Oncology, Pulmonology, University Hospital Münster, Münster, Germany.
  • Albring J; Department of Medicine A - Hematology, Hemostaseology, Oncology, Pulmonology, University Hospital Münster, Münster, Germany.
  • Mikesch JH; Department of Medicine A - Hematology, Hemostaseology, Oncology, Pulmonology, University Hospital Münster, Münster, Germany.
  • Schliemann C; Department of Medicine A - Hematology, Hemostaseology, Oncology, Pulmonology, University Hospital Münster, Münster, Germany.
  • Reicherts C; Department of Medicine A - Hematology, Hemostaseology, Oncology, Pulmonology, University Hospital Münster, Münster, Germany.
  • Berdel WE; Department of Medicine A - Hematology, Hemostaseology, Oncology, Pulmonology, University Hospital Münster, Münster, Germany.
  • Lenz G; Department of Medicine A - Hematology, Hemostaseology, Oncology, Pulmonology, University Hospital Münster, Münster, Germany.
  • Stelljes M; Department of Medicine A - Hematology, Hemostaseology, Oncology, Pulmonology, University Hospital Münster, Münster, Germany. Electronic address: matthias.stelljes@ukmuenster.de.
Clin Lymphoma Myeloma Leuk ; 20(10): e724-e733, 2020 10.
Article em En | MEDLINE | ID: mdl-32646833
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante Homólogo / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Biespecíficos / Transplante de Células-Tronco Hematopoéticas / Inotuzumab Ozogamicina Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante Homólogo / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Biespecíficos / Transplante de Células-Tronco Hematopoéticas / Inotuzumab Ozogamicina Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Lymphoma Myeloma Leuk Ano de publicação: 2020 Tipo de documento: Article